Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
5.99
-0.18 (-2.92%)
At close: Aug 8, 2025, 4:00 PM
6.00
+0.01 (0.17%)
After-hours: Aug 8, 2025, 4:29 PM EDT
Paramount Global Market Cap
Nuvectis Pharma has a market cap or net worth of $152.74 million as of August 8, 2025. Its market cap has increased by 19.73% in one year.
Market Cap
152.74M
Enterprise Value
125.95M
1-Year Change
19.73%
Ranking
Category
Stock Price
$5.99
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $152.74M, an increase of 163.32%. That is a compound annual growth rate of 31.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 152.74M | 46.13% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |